| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 114,914 | 114,183 | 116,658 | 119,903 | | Cost of Revenue | 38,631 | 37,879 | 41,866 | 38,893 | | | Gross Profit | 76,283 | 76,304 | 74,792 | 81,010 | | | Operating Expenses | | Research Development | 24,200 | 25,551 | 25,852 | 24,907 | | Selling General and Administrative | 30,316 | 30,827 | 30,719 | 35,171 | | Non Recurring | 13,587 |
-
|
-
| 3,891 | | Others | 327 | 315 | 318 | 111 | | | | Total Operating Expenses | 68,430 |
-
|
-
| 64,080 | | | | Operating Income or Loss | 21,440 | 19,611 | 17,903 | 16,930 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,988 | (2,575) | 66 | (33) | | Earnings Before Interest And Taxes | 10,841 | 17,036 | 17,969 | 16,897 | | Interest Expense | 67 | 57 | 55 | 66 | | Income Before Tax | 10,774 | 16,979 | 17,914 | 16,831 | | Income Tax Expense | 1,373 | 7,226 | 5,549 | 4,060 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,401 | 9,753 | 12,365 | 12,771 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 1,096 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,401 | 9,753 | 12,365 | 13,867 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,401 | $9,753 | $12,365 | $13,867 |
|
0.26% Nasdaq 
Income Statement
